Table 5 HbA1c change in patients whose anti-diabetic medication was not changed

From: Observational Study of Effects of Saroglitazar on Glycaemic and Lipid Parameters on Indian Patients with Type 2 Diabetes

Lab parameters

Baseline Mean ± SD

Follow up Mean ± SD

Mean change from baseline

P value

HbA1c (%) [n = 13]

7.93 ± 1.69

6.91 ± 1.09

−1.02

0.024

Back to article page